The US AI Drug Discovery Market is expanding rapidly as pharmaceutical and biotechnology companies increasingly adopt artificial intelligence to improve drug research and development. According to Market Research Future, the US market was valued at approximately USD 211.57 million in 2024 and is projected to reach USD 2.49 billion by 2035, growing at a CAGR of 25.15% from 2025 to 2035.

According to a recent report by Market Research Future, increasing investment in AI technologies is one of the major factors supporting market expansion. Machine learning, deep learning, natural language processing, knowledge graphs, and robotic process automation are increasingly being integrated into pharmaceutical research workflows. These technologies can help researchers analyze complex datasets, identify potential drug targets, evaluate compounds, and improve development efficiency.

The market is also benefiting from stronger collaboration between pharmaceutical companies, biotechnology firms, technology providers, and academic institutions. Such partnerships allow organizations to combine pharmaceutical expertise with advanced computational capabilities. Growing regulatory support for the appropriate integration of AI into drug development is another factor encouraging adoption.

Among applications, target identification currently represents the largest segment, while drug repurposing is identified as a rapidly growing area. AI can analyze existing drug and biological datasets to identify potential new therapeutic applications, helping researchers explore opportunities that may require less time than developing completely new compounds.

By technology, machine learning holds a leading position, while natural language processing is gaining momentum through its ability to analyze scientific literature and large volumes of unstructured information. Pharmaceutical companies remain the largest end-user segment, while biotechnology firms are experiencing strong expansion as smaller organizations increasingly incorporate AI into their research pipelines.

The future Growth outlook for the US AI Drug Discovery Market remains highly positive. Rising demand for personalized medicine, increasing computational power, expanding biomedical datasets, and continued investment in AI-enabled pharmaceutical research are expected to create significant opportunities through 2035.

FAQs

1. What is the US AI Drug Discovery Market?
It covers AI technologies, platforms, and applications used to support drug discovery and pharmaceutical research in the United States.

2. What is driving the US AI Drug Discovery Market?
Increasing AI investment, pharmaceutical R&D needs, personalized medicine, computational advances, and collaboration between technology and life-science companies are major drivers.

3. What is the projected market size by 2035?
Market Research Future projects the US AI Drug Discovery Market to reach approximately USD 2.49 billion by 2035.

4. Which technology dominates the market?
Machine learning is currently the leading technology segment, while natural language processing and deep learning are gaining importance.